0 likes | 10 Views
The global Eplerenone market is projected to experience substantial growth during the forecast period (2024-2030). Eplerenone, a potassium-sparing diuretic, is primarily used to treat heart failure and high blood pressure. The increasing prevalence of cardiovascular diseases, coupled with the growing geriatric population, is driving market demand. Additionally, the rising awareness about the importance of early diagnosis and treatment of heart conditions is further fueling market expansion.
E N D